An Analysis of Benefits and Challenges of Graduation from LDC:
An Analysis of Benefits and Challenges of Graduation from LDC:
复制标题
从 LDC 毕业的好处和挑战分析：
DOI：
10.11363/kaihatsukogaku.41.205
复制
发表时间：
2022
影响因子：
--
通讯作者：
三森八重子
中科院分区：
文献类型：
--
作者：
川島真 ; 小嶋華津子(編);早尻正宏;三森八重子
孟加拉国作为最不发达国家，拥有强大的制药业。通过利用 TRIPS 赋予最不发达国家的特权，孟加拉国公司可以生产受专利保护的药物，并在该国和其他国家作为“仿制药”销售。得益于医药行业良好的经营业绩，孟加拉国在过去几十年中实现了快速经济发展，预计最早于2026年从LDC毕业。本研究将考察孟加拉国制药业的现状，然后考察从 LDC 毕业对该行业的影响。
Bangladesh, unusually as an LDC, has strong pharmaceutical industry. By utilizing privilege given for LDCs under the TRIPS, Bangladesh companies can produce patent protected drugs and sell them as “generic drugs” in the country and other countries. Partly due to good business performance of the pharmaceutical industry, Bangladesh achieved rapid economic development over the past decades, and is scheduled to graduate from LDC in 2026 at the earliest. This study will examine the current status of Bangladesh pharmaceutical industry and then examine the impact of graduation from LDC on the industry.